Enzerna Biosciences is a pre-clinical stage company.
Enzerna has raised $250K in total funding. The most recent round was Debt Financing. The last funding was announced in November 2022.
Enzerna's investors include North Carolina Biotechnology Center.
Enzerna is headquartered in Morrisville, United States.
Enzerna Biosciences is a pre-clinical stage company.
Enzerna is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enzerna — Funding & Investors." VCBacked, November 8, 2022, https://www.vcbacked.co/company/enzerna. Accessed August 14, 2026.
VCBacked. (2022). Enzerna — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/enzerna
{{cite web |title=Enzerna — Funding & Investors |url=https://www.vcbacked.co/company/enzerna |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated